Search

everythinglearnresearchcommunity

for

Search:↓

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Spironolactone can reduce hair growth in women with hirsutism.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Liposomes improve finasteride delivery for hair loss treatment, making it a promising option for topical use.

Hair hormone levels can indicate obesity-related changes and are useful for research and clinical practice.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

Genetic and environmental factors, like smoking and exercise, affect male hair loss.

Finasteride complexes with HPβCD and polymers improve solubility, potentially enhancing hair loss treatment.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Low prolactin in young women may increase heart and metabolism risks.

Drug repurposing offers faster, cheaper drug development but faces challenges like safety, ethics, and funding.

Finasteride has a higher risk of reproductive side effects than minoxidil.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Minoxidil 5% caused skin discoloration in a man using it for hair loss.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Two people lost a lot of hair because of epilepsy drugs, but their hair grew back after changing medication.

Most kidney transplant patients in the study had skin problems, often related to infections, medication side effects, or skin cancer risks.

Genomic approach finds new possible treatments for hair loss.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Iron oxide nanoparticles improve skin penetration and drug release for hair loss treatment.

HIV patients with lower CD4 T cell counts often have more skin problems.

The seeds of Abrus precatorius, when processed, can prevent hair loss more effectively than common treatments.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Patch testing helps find allergens in minoxidil treatments, but doesn't ensure alternatives will be tolerated.

High doses of cyclosporine A increase testosterone conversion, possibly boosting hair growth.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Dr. Vera H. Price's 1979 work emphasizes the importance of accurate diagnosis and personalized treatment for hair loss.

Intradermal testing can better detect corticosteroid allergies than patch testing.